Detection of gyrA ser83 mutation and parC gene amplification in E.coli and Klebsiella pneumoniae from tertiary care hospital, Puducherry
Journal Title: IP International Journal of Medical Microbiology and Tropical Diseases - Year 2017, Vol 3, Issue 4
Abstract
Introduction: Fluoroquinolones are the broad spectrum antibiotics and recently the clinical isolates of Enterobacteriaceae species had slowly extend the high resistance towards them. The point mutation in gyrA gene had showed decreased susceptibility to ciprofloxacin and resistant to nalidixic acid. The aim of the present study was to identify gyrA and parC genes and gyrA ser83 mutation among clinical isolates of Escherichia coli and Klebsiella pneumoniae by RFLP. Methods: A total of 100 clinical strains of both Escherichia coli and Klebsiella pneumoniae were collected from tertiary care hospital from Pondicherry. All the strains were subjected to antimicrobial susceptibility pattern testing by disc diffusion method as per the Clinical Laboratory Standard Institute (CLSI2012). PCR based screening of gyrA and parC was carried out and additional analysis of gyrA ser83-phe mutation in E.coli and K.pneumoniae by agarose gel electrophoresis. Results: Variation in both ciprofloxacin and nalidixic acid resistance were showed in the (100) clinical isolates of E.coli and K. pneumoniae were reported earlier. GyrA and parC genes were detected in both susceptible and resistant isolates of E.coli and K.pneumoniae. Among them, E.coli showed 100% (50/50) and K.pneumoniae showed 84% (42/50) positivity for gyrA while 78% (39/50) and 64% (32/50) positivity for parC. PCR-RFLP results indicated gyrA ser83 mutation in 84% (42/50) of E.coli and 66% (33/50). The results also shows that E.coli is less susceptible to fluoroquinolones compared to K.pneumoniae. Conclusion: The overall resistance were increased for the ciprofloxacin and nalidixic acid among clinical isolates of E.coli and K. pneumoniae due to gyrA ser83-phe mutation. The antimicrobial resistance to fluoroquinolone drugs indicate the rapid genetic modifications undertaken by Enterobacteriaceae species and need for routine screening for resistance to develop next generation drugs.
Authors and Affiliations
G. Muthu, T. Mangaiyarkarasi, Vishnuprabu . , E. Sathishkumar, S. Srivani
Keywords
Related Articles
- EP ID EP306701
- DOI 10.18231/2455-6807.2017.0040
- Views 106
- Downloads 0
Seroprevalence of chikungunya fever in a tertiary care hospital in North Karnataka
Introduction Chikungunya disease is caused by Chikungunya virus an Alpha virus under the family Togaviridae transmitted through the vector Aedes spp mosquitoes The sudden onset of very high fever along with rash and seve...
Isolation & study of multidrug resistant Acinetobacter from various clinical samples in a tertiary care hospital
Introduction: Nosocomial infections with Acinetobacter are being increasingly reported worldwide from debilitated& Critical care patients. Multidrug resistance among Acinetobacter are now a major cause of concern. So the...
Study of intestinal parasites in food handlers in a tertiary care centre in Kanchipuram
nbspIntroduction Food handlers with poor hygiene working in food establishment areas have been reported as a potential source of helminths amp protozoans all over the world Individuals with symptoms of parasitic infectio...
Seroprevalence of Chikungunya virus infection in Ballari and nearby districts of Karnataka
Background and Objective: Chikungunya virus (CHIKV) is an arthropod-borne virus, causes fever and nonspecific clinical manifestations similar to malaria and other bacterial infections, it is not routinely tested at the h...
A study of Mycotic keratitis in a tertiary care hospital in North-East Karnataka
Introduction: Fungal keratitis is a major blinding eye disease in Asia, has been known since 1879, when Leber reported first case. The acuteness of problem in Northeast Karnataka area is due to hot and dry environment wi...